BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18931713)

  • 1. [Influence factors on the formation of mammospheres from breast cancer stem cells].
    Huang MZ; Zhang FC; Zhang YY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
    Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
    Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dendritic cells infected by recombinant adeno-associated virus with CEA gene to induce antigen-specific CTL response to CD44(+)CD24(-/low) cells from MCF-7 breast cancer cell line].
    Wang XL; Ma B; Jia J; Yuan YH; Yan Y; Di LJ; Song GH; Yu J; Ren J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):173-8. PubMed ID: 21503107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].
    Lu ZH; Jia J; Ren J; Ma B; DI LJ; Song GH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):480-5. PubMed ID: 18931709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
    Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
    Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cell dissociation on identification of breast cancer stem cells.
    Quan Y; Yan Y; Wang X; Fu Q; Wang W; Wu J; Yang G; Ren J; Wang Y
    Cancer Biomark; 2012-2013; 12(3):125-33. PubMed ID: 23481571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors.
    Wang R; Lv Q; Meng W; Tan Q; Zhang S; Mo X; Yang X
    J Thorac Dis; 2014 Jun; 6(6):829-37. PubMed ID: 24977009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
    Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
    Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
    Phillips TM; McBride WH; Pajonk F
    J Natl Cancer Inst; 2006 Dec; 98(24):1777-85. PubMed ID: 17179479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells.
    Montales MT; Rahal OM; Kang J; Rogers TJ; Prior RL; Wu X; Simmen RC
    Carcinogenesis; 2012 Mar; 33(3):652-60. PubMed ID: 22219179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.
    Lü X; Xu K; Lü H; Yin Y; Ma C; Liu Y; Li H; Suo Z
    Ultrastruct Pathol; 2011 Apr; 35(2):72-8. PubMed ID: 21299347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the stemness potency of
    Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
    Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].
    Li Z; Liu CP; He YL; Tian Y; Huang T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):547-9. PubMed ID: 18798490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line.
    Ambrose JM; Veeraraghavan VP; Vennila R; Rupert S; Sathyanesan J; Meenakshisundaram R; Selvaraj S; Malayaperumal S; Kullappan M; Dorairaj S; Gujarathi JR; Gandhamaneni SH; Surapaneni KM
    J Egypt Natl Canc Inst; 2022 Dec; 34(1):51. PubMed ID: 36504339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.